0001209191-12-035452.txt : 20120626
0001209191-12-035452.hdr.sgml : 20120626
20120626175418
ACCESSION NUMBER: 0001209191-12-035452
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120625
FILED AS OF DATE: 20120626
DATE AS OF CHANGE: 20120626
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LUNDBERG MAGNUS
CENTRAL INDEX KEY: 0001235944
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-28298
FILM NUMBER: 12928048
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ONYX PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001012140
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943154463
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 249 E. GRAND AVE.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-266-0000
MAIL ADDRESS:
STREET 1: 249 E. GRAND AVE.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0305
4
2012-06-25
0
0001012140
ONYX PHARMACEUTICALS INC
ONXX
0001235944
LUNDBERG MAGNUS
C/O ONYX PHARMACEUTICALS, INC.
249 EAST GRAND AVE.
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Common Stock
2012-06-25
4
M
0
5000
12.11
A
15616
D
Common Stock
2012-06-25
4
S
0
5000
65.175
D
10616
D
Stock Option (Right to Buy)
12.11
2012-06-25
4
M
0
5000
0.00
D
2004-06-09
2013-06-09
Common Stock
5000
0
D
Shares sold pursuant to a 10b5-1 plan.
The shares were sold at prices between $64.90 and $65.30. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
/s/ Warren DeSouza, Attorney-in-fact
2012-06-26